Metformin protects red blood cells against rotenone induced oxidative stress and cytotoxicity

References

• Arbos, K.A., et al., 2008. Human erythrocytes as a system for evaluating the antioxidant capacity of vegetable extracts. Nutrition research, 28 (7), 457–463.
   PubMed Web of Science ®Google Scholar
• Balcerczyk, A. and Bartosz, G., 2003. Thiols are main determinants of total antioxidant capacity of cellular homogenates. Free radical research, 37 (5), 537–541.
   PubMed Web of Science ®Google Scholar
• Barzilai, N., et al., 2016. Metformin as a tool to target aging. Cell metabolism, 23 (6), 1060–1065.
   PubMed Web of Science ®Google Scholar
• Benzie, I.F. and Strain, J.J., 1996. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Analytical biochemistry, 239 (1), 70–76.
   PubMed Web of Science ®Google Scholar
• Bindokas, V.P., et al., 2003. Visualizing superoxide production in normal and diabetic rat islets of Langerhans. The journal of biological chemistry, 278 (11), 9796–9801.
   PubMed Web of Science ®Google Scholar
• Chakraborty, A., Chowdhury, S., and Bhattacharyya, M., 2011. Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. Diabetes research and clinical practice, 93 (1), 56–62.
   PubMed Web of Science ®Google Scholar
• Chaves, R.S., et al., 2016. Presence of insoluble Tau following rotenone exposure ameliorates basic pathways associated with neurodegeneration. IBRO reports, 1, 32–45.
   PubMedGoogle Scholar
• Chukwunonso Obi, B., et al., 2016. Comparative study of the antioxidant effects of metformin, glibenclamide, and repaglinide in alloxan-induced diabetic rats. Journal of diabetes research, 2016, 1.
   Web of Science ®Google Scholar
• Cimen, M.Y., 2008. Free radical metabolism in human erythrocytes. Clinica chimica acta: international journal of clinical chemistry, 390 (1–2), 1–11.
   PubMed Web of Science ®Google Scholar
• Cristani, M., et al., 2016. Circulating advanced oxidation protein products as oxidative stress biomarkers and progression mediators in pathological conditions related to inflammation and immune dysregulation. Current medicinal chemistry, 23 (34), 3862–3882.
   PubMed Web of Science ®Google Scholar
• Cui, H., Kong, Y., and Zhang, H., 2012. Oxidative stress, mitochondrial dysfunction, and aging. Journal of signal transduction, 2012, 1.
   Google Scholar
• De Grey, A.D., 2005. The plasma membrane redox system: a candidate source of aging-related oxidative stress. Age (Dordr), 27 (2), 129–138.
   PubMedGoogle Scholar
• Diniz Vilela, D., et al., 2016. The role of metformin in controlling oxidative stress in muscle of diabetic rats. Oxidative medicine and cell longevity, 2016, 6978625.
   PubMed Web of Science ®Google Scholar
• Dumaswala, U.J., et al., 1999. Protein and lipid oxidation of banked human erythrocytes: role of glutathione. Free radical biology and medicine, 27 (9–10), 1041.
   PubMed Web of Science ®Google Scholar
• Esterbauer, H. and Cheeseman, K.H., 1990. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods in enzymology, 186, 407–421.
   PubMed Web of Science ®Google Scholar
• Esteve-Rudd, J., et al., 2011. Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina. Neurobiology of disease, 44 (1), 102–115.
   PubMed Web of Science ®Google Scholar
• Fiske, C. and Subbarow, Y., 1925. The colorimetric determination of phosphorus. The journal of biological chemistry, 66, 375–400.
   Google Scholar
• Fujino, T., et al., 2000. Identification of oxidized protein hydrolase of human erythrocytes as acylpeptide hydrolase. Biochimica et biophysica acta, 1478 (1), 102–112.
   PubMedGoogle Scholar
• Garg, G., et al., 2017a. Antiaging effect of metformin on brain in naturally aged and accelerated senescence model of rat. Rejuvenation research, 20 (3), 173–182.
   PubMed Web of Science ®Google Scholar
• Garg, G., et al., 2017b. Metformin alleviates altered erythrocyte redox status during aging in rats. Rejuvenation research, 20 (1), 15–24.
   PubMed Web of Science ®Google Scholar
• Griffin, S.J., Leaver, J.K., and Irving, G.J., 2017. Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes. Diabetologia, 60, 1620–1629.
   PubMed Web of Science ®Google Scholar
• Hale, J.P., Winlove, C.P., and Petrov, P.G., 2011. Effect of hydroperoxides on red blood cell membrane mechanical properties. Biophysical journal, 101 (8), 1921–1929.
   PubMed Web of Science ®Google Scholar
• Heinz, S., et al., 2017. Mechanistic investigations of the mitochondrial complex i inhibitor rotenone in the context of pharmacological and safety evaluation. Scientific reports, 7, 45465.
   PubMed Web of Science ®Google Scholar
• Hu, M.L., 1994. Measurement of protein thiol groups and glutathione in plasma. Methods in enzymology, 233, 380–385.
   PubMed Web of Science ®Google Scholar
• Huang, W.H., Wang, Y., and Askari, A., 1992. (Na+ + K+)-ATPase: inactivation and degradation induced by oxygen radicals. International journal of biochemistry, 24 (4), 621–626.
   PubMedGoogle Scholar
• Jelkmann, W., ed., 2012. Functional significance of erythrocytes. London: Imperial Press.
   Google Scholar
• Jiang, X.W., et al., 2017. Rotenone induces nephrotoxicity in rats: oxidative damage and apoptosis. Toxicology mechanisms and methods, 27 (7), 528–536.
   PubMed Web of Science ®Google Scholar
• Kale, M., et al., 1999. Lipid peroxidative damage on pyrethroid exposure and alterations in antioxidant status in rat erythrocytes: a possible involvement of reactive oxygen species. Toxicology letters, 105 (3), 197–205.
   PubMed Web of Science ®Google Scholar
• Kanigur-Sultuybek, G., et al., 1995. The effect of metformin on insulin receptors and lipid peroxidation in alloxan and streptozotocin induced diabetes. Journal of basic and clinical physiology and pharmacology, 6, 271–280.
   PubMedGoogle Scholar
• Kashyap, M.P., et al., 2011. Monocrotophos induced apoptosis in PC12 cells: role of xenobiotic metabolizing cytochrome P450s. PLoS one, 6 (3), e17757.
   PubMed Web of Science ®Google Scholar
• Kasten, M., et al., 2010. Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology, 74, 1655, author reply 1655–1656.
   PubMedGoogle Scholar
• Krstic, D.Z., et al., 2008. Inhibition of AChE by malathion and some structurally similar compounds. Journal of enzyme inhibition and medicinal chemistry, 23 (4), 562–573.
   PubMed Web of Science ®Google Scholar
• Lang, F., et al., 2008. Eryptosis, a window to systemic disease. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology, 22 (5–6), 373–380.
   PubMedGoogle Scholar
• Levine, R.L., et al., 1990. Determination of carbonyl content in oxidatively modified proteins. Methods in enzymology, 186, 464–478.
   PubMed Web of Science ®Google Scholar
• Li, N., et al., 2003. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. Journal of biological chemistry, 278 (10), 8516–8525.
   PubMed Web of Science ®Google Scholar
• Lowry, O.H., et al., 1951. Protein measurement with the Folin phenol reagent. Journal of biological chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• Lupescu, A., et al., 2012. Induction of apoptotic erythrocyte death by rotenone. Toxicology, 300 (3), 132–137.
   PubMed Web of Science ®Google Scholar
• Malek, M., et al., 2013. Risk of cancer in diabetes: the effect of metformin. ISRN endocrinology, 2013, 636927.
   PubMedGoogle Scholar
• Marchesi, V.T. and Palade, G.E., 1967. The localization of Mg-Na-K-activated adenosine triphosphatase on red cell ghost membranes. The journal of cell biology, 35 (2), 385–404.
   PubMed Web of Science ®Google Scholar
• Markowicz-Piasecka, M., et al., 2017. Metformin - a future therapy for neurodegenerative diseases: theme: drug discovery, development and delivery in Alzheimer's disease guest editor: Davide Brambilla. Pharmaceutical research, 34 (12), 2614–2627.
   PubMed Web of Science ®Google Scholar
• Martin-Montalvo, A., et al., 2013. Metformin improves healthspan and lifespan in mice. Nature communications, 4, 2192.
   PubMed Web of Science ®Google Scholar
• Maruthur, N.M., et al., 2016. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Annals of internal medicine, 164 (11), 740–751.
   PubMed Web of Science ®Google Scholar
• Masella, R., et al., 2005. Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. Journal of nutritional biochemistry, 16 (10), 577–586.
   PubMed Web of Science ®Google Scholar
• Mihaylova, M.M. and Shaw, R.J., 2011. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nature cell biology, 13 (9), 1016–1023.
   PubMed Web of Science ®Google Scholar
• Mohanty, J.G., Nagababu, E., and Rifkind, J.M., 2014. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Frontiers in physiology, 5, 84.
   PubMed Web of Science ®Google Scholar
• Ojha, S., et al., 2015. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease. Drug design, development and therapy, 9, 5499–5510.
   PubMed Web of Science ®Google Scholar
• Onken, B. and Driscoll, M., 2010. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One, 5 (1), e8758.
   PubMed Web of Science ®Google Scholar
• Pandey, K.B. and Rizvi, S.I., 2011. Biomarkers of oxidative stress in red blood cells. Biomedical papers, 155 (2), 131–136.
   PubMed Web of Science ®Google Scholar
• Pandey, K.B. and Rizvi, S.I., 2014. Role of resveratrol in regulation of membrane transporters and integrity of human erythrocytes. Biochemical and biophysical research communications, 453 (3), 521–526.
   PubMed Web of Science ®Google Scholar
• Patil, S.P., et al., 2014. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice. Neuroscience, 277, 747–754.
   PubMed Web of Science ®Google Scholar
• Pizzimenti, S., et al., 2013. Interaction of aldehydes derived from lipid peroxidation and membrane proteins. Frontiers in physiology, 4, 242.
   PubMed Web of Science ®Google Scholar
• Pretorius, E. and Kell, D.B., 2014. Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases. Integrative biology, 6 (5), 486–510.
   PubMed Web of Science ®Google Scholar
• Reglinski, J., et al., 1988. Cellular response to oxidative stress at sulfhydryl group receptor sites on the erythrocyte membrane. Journal of biological chemistry, 263, 12360–12366.
   PubMed Web of Science ®Google Scholar
• Rizvi, S.I., Jha, R., and Maurya, P.K., 2006. Erythrocyte plasma membrane redox system in human aging. Rejuvenation research, 9 (4), 470–474.
   PubMed Web of Science ®Google Scholar
• Rizvi, S.I., et al., 2011. Erythrocyte plasma membrane redox system may determine maximum life span. Medical hypotheses, 76 (4), 547–549.
   PubMed Web of Science ®Google Scholar
• Rizvi, S.I. and Maurya, P.K., 2007. Alterations in antioxidant enzymes during aging in humans. Molecular biotechnology, 37 (1), 58–61.
   PubMed Web of Science ®Google Scholar
• Rizvi, S.I. and Srivastava, N., 2010. Erythrocyte plasma membrane redox system in first degree relatives of type 2 diabetic patients. International journal of diabetes mellitus, 2 (2), 119–121.
   Google Scholar
• Salman, Z.K., et al., 2013. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats. European journal of pharmacology, 714 (1–3), 448–455.
   PubMed Web of Science ®Google Scholar
• Saravanan, K.S., Sindhu, K.M., and Mohanakumar, K.P., 2007. Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model. Journal of pineal research, 42 (3), 247–253.
   PubMed Web of Science ®Google Scholar
• Savica, R., Rocca, W.A., and Ahlskog, J.E., 2010. When does Parkinson disease start? Archives of neurology, 67 (7), 798–801.
   PubMedGoogle Scholar
• Sherer, T.B., et al., 2003. Mechanism of toxicity in rotenone models of Parkinson's disease. Journal of neurosciences, 23 (34), 10756–10764.
   PubMed Web of Science ®Google Scholar
• Singh, A.K., et al., 2018. Rapamycin mitigates erythrocyte membrane transport functions and oxidative stress during aging in rats. Archives of physiology and biochemistry, 124 (1), 45–53.
   PubMed Web of Science ®Google Scholar
• Stadtman, E.R. and Berlett, B.S., 1998. Reactive oxygen-mediated protein oxidation in aging and disease. Drug metabolism and reviews, 30 (2), 225–243.
   PubMed Web of Science ®Google Scholar
• Stier, A., et al., 2015. Red blood cells open promising avenues for longitudinal studies of ageing in laboratory, non-model and wild animals. Experimental gerontology, 71, 118–134.
   PubMed Web of Science ®Google Scholar
• Suhail, M. and Rizvi, S.I., 1987. Red cell membrane (Na+ +K+)-ATPase in diabetes mellitus. Biochemical and biophysical research communications, 146 (1), 179–186.
   PubMed Web of Science ®Google Scholar
• Tanner, C.M., et al., 2011. Rotenone, paraquat, and Parkinson's disease. Environmental health and perspectives, 119 (6), 866–872.
   PubMed Web of Science ®Google Scholar
• Thevenod, F. and Friedmann, J.M., 1999. Cadmium-mediated oxidative stress in kidney proximal tubule cells induces degradation of Na+/K(+)-ATPase through proteasomal and endo-/lysosomal proteolytic pathways. Faseb journal, 13, 1751–1761.
   PubMed Web of Science ®Google Scholar
• Tsantes, A.E., et al., 2006. Redox imbalance, macrocytosis, and RBC homeostasis. Antioxidants and redox signaling, 8 (7–8), 1205–1216.
   PubMed Web of Science ®Google Scholar
• Uchendu, C., et al., 2014. Erythrocyte osmotic fragility and lipid peroxidation following chronic co-exposure of rats to chlorpyrifos and deltamethrin, and the beneficial effect of alpha-lipoic acid. Toxicology reports, 1, 373–378.
   PubMedGoogle Scholar
• Van Duijn, M.M., et al., 1998. Ascorbate stimulates ferricyanide reduction in HL-60 cells through a mechanism distinct from the NADH-dependent plasma membrane reductase. Journal of biological chemistry, 273 (22), 13415–13420.
   PubMed Web of Science ®Google Scholar
• Verma, R. and Nehru, B., 2009. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease. Neurochemistry international, 55 (6), 369–375.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat, V., et al., 1996. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney international, 49 (5), 1304–1313.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat, V., et al., 1998. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. Journal of immunology, 161, 2524–2532.
   PubMed Web of Science ®Google Scholar
• Zhou, G., et al., 2001. Role of AMP-activated protein kinase in mechanism of metformin action. The journal of clinical investigation, 108 (8), 1167–1174.
   PubMed Web of Science ®Google Scholar
• Zi, F., et al., 2018. Metformin and cancer: an existing drug for cancer prevention and therapy. Oncology letters, 15 (1), 683–690.
   PubMed Web of Science ®Google Scholar